REVISED: 7/03, 03/05, 04/08, 3/10, 11/11, 09/13, 3/14,1/15, 4/16
|
|
- Everett Riley
- 5 years ago
- Views:
Transcription
1 TITLE/DESCRIPTION: DEPARTMENT: PERSONNEL: BLOOD PRODUCT ADMINISTRATION CLINICAL LABORATORY ALL HOSPITAL EMPLOYEES EFFECTIVE DATE: 10/95 REVISED: 7/03, 03/05, 04/08, 3/10, 11/11, 09/13, 3/14,1/15, 4/16 RESPONSIBILITY FOR FINAL IDENTIFICATION CHECKS: In the Patient s Room or Outpatient IV Services, Transfusion Record Manager (TRM) must be used at the bedside to verify the patient and blood product. The person actually starting the transfusion and another nurse must together recheck the correspondence of blood product unit numbers and blood type labels on the unit, and the Blood Band Identification (BBID) number with the unit tag. Then ABSOLUTELY VERIFY that the patient identification (Name, DOB and MRN) on the unit tag corresponds to the armband and the blue blood bank armband identity of the patient. This verification must be documented by both persons, by electronically signing the Blood Administration Record in the HIS. This MUST occur at the bedside. In the Operating Suite, the person actually starting the transfusion and another nurse/md must together recheck the correspondence of the blood product unit numbers and blood type labels on the unit, and the BBID number with the unit tag. Then ABSOLUTELY VERIFY that the patient identification on the unit tag corresponds to the armband and the blue blood bank armband identity of the patient. This verification must be documented in the electronic OR Blood Administration Record, by typing in the identity of the administering and verifying personnel in the appropriate spaces. If any discrepancy arises as a result of these checks, the blood should be returned to the Blood Bank immediately. RETURN OF BLOOD PRODUCTS TO BLOOD BANK: All blood product units issued for transfusion should be started immediately after being issued. If it becomes apparent that the unit cannot be started immediately, it should be returned to the Blood Bank without delay (not kept at room temperature or placed in an unmonitored refrigerator). If the start of the transfusion is delayed, the following guidelines must be followed: a. The transfusion must be completed within 4 hours from issue from the controlled storage, not 4 hours from the start of administration
2 b. If the product temperature rises above 10 degrees, the product must remain on the unit and transfusion completed within 4 hours from issue from the controlled storage. c. If the product is not needed by the patient, but failed to be returned to the Blood Bank immediately and product is now out of temperature; the product must be returned and discarded by Blood Bank personnel to prevent re-issue. Due to rigid regulations and the need to curtail unnecessary loss of blood products, it is requested that the responsible nurse verify that transfusion can be started prior to pick-up of blood product. On difficult to stick patients, it is recommended that an I.V. be started with normal saline at a T.K.O. rate (EXCEPT WHERE INFUSION OF SALINE IS CONTRAINDICATED) before picking up the blood product. Blood products issued to the CVOR Pump Room are stored in a monitored refrigerator (except platelets) during the case. All un-used blood products should be returned to the Blood Bank within 20 minutes of the case ending, so the products will be available for transfusion in cardiac recovery if needed. ADMINISTRATION OF BLOOD PRODUCTS: The requirements for administration of blood products must be closely followed and the required documentation fully completed. In the administration of blood products, the final verification that the information on the patient's arm band, blood container label, and unit tag all correspond, must be the immediate responsibility of a registered nurse or physician. Prior to starting the blood product, the patient's blood pressure, pulse, respiration and temperature must be taken and recorded on the electronic Transfusion Record. BLOOD PRODUCTS SHOULD BE STARTED WITHIN 30 MINUTES AFTER ISSUE FROM BLOOD BANK. The unit should be entered only after it is determined that there is no reason not to start the transfusion. Pre-transfusion vital signs should be taken before spiking the unit. The blood product must be started and administered slowly for fifteen minutes, unless specified otherwise by the physician's orders. A nurse should stay with the patient for the first minutes to ensure there are no symptoms of a reaction. After fifteen minutes, the vital signs and temperature must be taken again and recorded on the transfusion record. If no adverse effects are apparent, the rate of flow should be increased such that the transfusion will be completed within two to three hours. The vital signs and temperature must again be taken at the conclusion of the transfusion. The time of completion of the transfusion must be recorded on the Transfusion Record, as well as the amount transfused. All electronic Transfusion Records should be complete within 72 hours.
3 If transfusion record results are not entered electronically, due to HIS downtime or other issues, the white paper Chart Copy must then be inserted in the patient's chart as part of their permanent medical record. The third hard copy of the unit tag MUST remain attached to the blood product unit, until transfusion is complete and the empty bag is discarded. All routine transfusions should be documented electronically in the Blood Administration Record. Emergent transfusions should be documented electronically in the Emergent Blood Administration Record. Emergency transfusions are primarily for use in the Emergency Department, Critical Care Units, and codes. Vital signs are not required on this document. There is a statement directing to the Vital Sign Flow sheet for Vital Signs. Any transfusion that is completed in 15 minutes or less should use this document. All blood product transfusions performed in the Operating Suite, should use the OR Blood Transfusion Record. This record is specifically tailored to the needs of the operating room staff. All patients receiving blood product transfusions as an outpatient in the Outpatient IV Services area will receive a Post Transfusion Letter prior to discharge. The Post- Transfusion Letter details symptoms noted within 24 hours post-transfusion, that may be indicative of a potential transfusion reaction. PRECAUTIONS: The administration of any blood product must be discontinued at FOUR HOURS from issue of product from controlled storage. All blood products are transfused using the Y type blood set. Blood may be warmed as it passes through the set with a special blood warmer having a visible thermometer and an audible alarm. Temperature should not be allowed to exceed 42 0 C; blood should be discarded if temperature exceeds 42 0 C. Any devices (blood warmer) used during the transfusion should be noted on the transfusion record so the Blood Bank Director may be fully aware of device usage in the event a transfusion reaction investigation becomes necessary. If multiple units are given, a new set should be used with each unit. Addition of drugs or medication, including those intended for intravenous use, must not be added to blood products. Only 0.9% Sodium Chloride injection, USP, may be added to blood products. If a physician specifically requests the addition of a medication, the Blood Bank Director must be contacted PRIOR to the addition. Medications are not to be omitted due to the administration of blood products unless specifically ordered to do so by a physician. If necessary, the nurse may start a heparin
4 lock to give medication through. Under no circumstance should medication or other substances be given through an IV line in which blood is being infused. Persons overseeing patient transfusions must be knowledgeable of the signs and symptoms of the various types of transfusion reaction. A complication of a blood transfusion is a hemolytic transfusion reaction. There are several other types, as shown in Table 1 (attached). During transfusion, the condition of the patient should be checked as frequently as circumstances allow, in that the severity of any given type of reaction is almost always worsened by the continued transfusion of the offending blood product. The slow rate of blood flow during the first part of a transfusion is to permit the possible detection of reaction symptoms without giving the patient a large volume of the unit. The major symptoms and signs of a reaction are chills, fever, headache, backache, hematuria, localized edema, bronchial spasm, skin rash or wheals, and itching. Some patients may experience a mild chilly sensation simply as a result of receiving the blood at refrigerated temperature, this may require evaluation by the head nurse in the individual case. Some judgment may also be required with regard to the appearance of fever during the transfusion in a patient already experiencing documented recurrent febrile episodes. TRANSFUSION REACTION PROCEDURE: If any signs or symptoms of a reaction appear during a transfusion, the following sequence of procedures will apply: IN ALL CASES EXCEPT "HIVES" ONLY; cut off the flow of blood through the recipient set and remove set from venous catheter -- DO NOT REMOVE CATHETER. Start a unit of normal saline at a T.K.O. rate to prevent clotting in the needle. NOTE: If no other symptoms are present except "hives" reduce the rate of infusion and stop only if directed to do so by the physician. RECHECK the patient's identification with the blood product. Take the patient's vital signs and temperature. Notify the Blood Bank. Notify the attending physician. On the transfusion portion of the Blood Administration Document (Transfusion Record), document vital signs, time transfusion discontinued and approximate amount of blood product infused.
5 Order Transfusion Reaction Work-Up in HIS and enter the requested information. Send blood product bag (with set intact but tied off or clamped (including saline bag) in a plastic bag with Transfusion Record form attached to outside of plastic bag (do not place inside with blood product bag). Send the FIRST AVAILABLE urine specimen to the Lab. RECORD URINE OUTPUT FOR THE NEXT TWENTY-FOUR HOUR PERIOD SUBSEQUENT TO THE APPARENT REACTION. Draw a blood bank sample for repeat testing and deliver to the blood bank. The blood bank staff will generate a transfusion reaction investigation report. TRANSFUSION REACTIONS: OTHER TRANSFUSION COMPLICATIONS ANY transfusion related incident should be reported IMMEDIATELY to the Blood Bank/Laboratory Medical Director or the Laboratory Director, regardless of the outcome to the patient (transfusion of blood products to the wrong recipient, transfusion of the wrong unit to a patient, discovery of a discrepancy between a patient's historical blood type and type currently recorded on paperwork, or appearance of delayed transfusion reaction symptoms). Laboratory will notify nursing personnel of discrepancies discovered in paperwork PRIOR to transfusion. The development of unexplained acute liver dysfunction or clinical symptoms suggestive of hepatitis (within two weeks to six months) after transfusion of blood or blood components should be reported to the Medical Director or Laboratory Director. The FDA requires investigation of such cases as possible post transfusion hepatitis, and notification of the blood supplier.
6 Table 1: Signs and Symptoms of a Transfusion Reaction
St. Vincent s East Page 1 of 5
St. Vincent s East Page 1 of 5 TITLE: PATIENT CARE PRACTICE GUIDELINE CARE OF PATIENTS BLOOD AND BLOOD COMPONENTS - ADMINISTRATION FACILITY: FUNCTION: ORIGINATING DEPT: St. Vincent s East HOSPITAL SHARED
More informationBlood and Blood Products Administration
NCAL Patient Care Services 2016 Blood and Blood Products Administration Objectives: On completing this module, you will be able to: Identify blood group systems Describe compatibility requirements List
More informationReviewed 8/31/2013. Susan Parrish MSN RN
Reviewed 8/31/2013 Susan Parrish MSN RN After completion of this self study packet, the nurse should be able to: Identify the required components of the physician's order for blood transfusion products.
More informationDESCRIPTION/OVERVIEW This document standardizes the transfusion of packed red blood cells and/or other blood components.
Applies To: UNM Hospitals & UNMCC Responsible Department: Blood Bank Revised: 5/2017 Procedure Patient Age Group: ( ) N/A (X) All Ages ( ) Newborns ( ) Pediatric ( ) Adult DESCRIPTION/OVERVIEW This document
More informationSample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee
Sample A guide to development of a hospital blood transfusion Policy at the hospital level Name of Policy Blood Transfusion Policy Effective from April 2009 Approved by Hospital Transfusion Committee A
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: ISSUED FOR: NURSING PROCEDURE Nursing DATE: REVIEWED: PAGES: RESPONSIBILITY: RN, LPN I, LPN II Per Job Description 03/93 2/18 1 of 6 PURPOSE: KNOWLEDGE BASE: To provide
More informationFY 15 BLOOD ADMINISTRATION/REACTION
1 FY 15 BLOOD ADMINISTRATION/REACTION Patient Care Services Policies PCS-205 Blood and Blood Components Transfusion: Initiation & Maintenance PCS-206 Blood and Blood Components: Transfusion Reaction PCS-207
More informationNOTE: Massive Transfusion Protocol (MTP) go to Appendix 17 and 17a for nursing guidelines and algorithm.
NURSING PROCEDURE TITLE: BLOOD PRODUCTS ADMINISTRATION Crossmatched & Uncrossmatched Products: Packed red blood cells, platelets, plasma, cryoprecipitate (homologous, autologous & directed donor) A. Prior
More informationTransfusion of Blood Components and Products
Approved by: Vice President & Chief Medical Officer; and Vice President & Chief Operating Officer Transfusion of Blood Components and Products Corporate Policy & Procedures Manual Number: VII-B-395 Date
More informationSARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY
SARASOTA MEMORIAL HEALTH CARE SYSTEM CORPORATE POLICY TITLE: ADMINISTRATION OF BLOOD AND EFFECTIVE DATE: REVIEWED/REVISED DATE: POLICY TYPE: 10/15/79 08/31/17 Clinical 1 of 7 Non-Clinical Job Title of
More informationBlood Administration for Community Patients Policy
Blood Administration for Community Patients Policy Policy Title: Blood Administration for Community Patients Policy Policy Reference Number: PrimCare08/15 Implementation Date: Review Date: July 2010 Responsible
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE ORDERING, OBTAINING, IDENTIFICATION AND ADMINISTRATION OF BLOOD PRODUCTS (RBC, CRYOPRECIPITATE) BLOOD REACTIONS ADULTS AND PEDIATRICS DATE: REVIEWED:
More informationATLANTICARE HEALTH SYSTEM AtlantiCare Regional Medical Center ID #: 3581 DEPARTMENT: GENERAL CATEGORY: PROVISION OF CARE
POLICY: Blood products must be administered in accordance with the procedures defined below. PURPOSE: To provide guidelines or the issue, initiation and termination of transfusion of blood products as
More informationINPATIENT Annual Core Competency Performance Stations (Nursing) 2010 (Unlicensed Staff Direct & Non-Direct Care Providers * )
County of Los Angeles INPATIENT Annual Core Competency Performance Stations (Nursing) 2010 (Unlicensed Staff Direct & Non-Direct Care Providers * ) * Staff who work in patient care areas 1 ANNUAL CORE
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE TRANSFUSION OF BLOOD COMPONENTS AND PRODUCTS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Transfusion Medicine Network Not applicable DOCUMENT #
More informationADMINISTRATION OF BLOOD PRODUCTS (RED CELLS, PLATELETS, PLASMA, & CRYOPRECIPITATE) NICU SYRINGE METHOD
PURPOSE ADMINISTRATION OF BLOOD PRODUCTS To provide guidelines for the administration of blood products (red blood cells, platelets, plasma and cryoprecipitate) via syringe delivery in NICU SITE APPLICABILITY
More informationDepartment Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual
Department Policy Code: D: MM-5615 Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Chemotherapy Purpose: Ensure
More informationMedication Administration Using the Home Pump (Eclipse)
Medication Administration Using the Home Pump (Eclipse) Phone Number: Nurse/Contact: Receiving IV Therapy in the Home Your doctor has ordered for you to receive your IV medication at home. Receiving IV
More informationSafe Blood Transfusion
Safe Blood Transfusion Cardiff & Vale uhb & Welsh Blood Service Education Sub-group Objectives Complex pathway Overview ~ pre-transfusion blood sampling ~ collection from blood bank fridge ~ administration
More informationInfusion Therapy Learning Exercise: Infusion Documentation
Infusion Therapy Learning Exercise: Infusion Documentation INFUSION OF DOCUMENT IN DOCUMENT PERIPHERAL PICC LINE BLOOD TRANSFUSION SPINAL EPIDURAL CLPNA Infusion Therapy: Infusion Documentation Exercise
More informationWYOMING STATE BOARD OF NURSING ADVISORY OPINION
WYOMING STATE BOARD OF NURSING ADVISORY OPINION INTRAVENOUS THERAPY BY LICENSED PRACTICAL NURSES Advisory Opinion Number: 03-123 Board Meeting Date: April 28-May 1, 2003 January 7-10, 2008 Introduction:
More informationSTANDARDIZED PROCEDURE FEMORAL VENOUS BLOOD DRAW (Adult, Peds)
I. Definition The Femoral venous blood draw (FVBD) is the procedure of performing a needle stick into the femoral vein for the purpose of drawing blood work that will assist in lab monitoring. II. Background
More informationBlood / Blood Products Transfusion A Liquid Transplant
Blood / Blood Products Transfusion A Liquid Transplant Caroline Holt Specialist Practitioner of Transfusion caroline.holt@tgh.nhs.uk Tel : 922 5484 Mob: 07759260044 The Transfusion Team Gillian Lewis Blood
More informationAll about Your Implanted Venous Access Device (IVAD, Port )
All about Your Implanted Venous Access Device (IVAD, Port ) Your doctor has chosen an Implanted Venous Access Device (IVAD) for you based on your treatment needs. Because the IVAD can remain in place for
More informationDepartment of Public Health Infection Control Survey
Patient Care Services, uality and Safety Being Ready for Every Patient Every Day Department of Public Health Infection Control Survey Resource Guide for Patient Care ssociates Excellence Every Day The
More informationThis document is NOT FOR PROMOTIONAL USE. Do not copy, distribute, or share with physicians, staff, or patients. FOR INTERNAL USE ONLY.
SIMPONI ARIA Infusion Suite Module Summary Page 1 of 5 The trademark, SIMPONI ARIA, has received provisional acceptance from the FDA. SIMPONI ARIA is an investigational agent currently under review by
More informationText-based Document. Blood Transfusion Education in Medical-Surgical Acute Care Hospitals in the U.S. Downloaded 27-Jun :58:31
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More informationPatient & Family Guide. Blood Transfusion. Aussi disponible en français : La transfusion sanguine (FF )
Patient & Family Guide 2017 Blood Transfusion Aussi disponible en français : La transfusion sanguine (FF85-1811) www.nshealth.ca Blood Transfusion You have been given this pamphlet because you or your
More informationWYOMING STATE BOARD OF NURSING ADVISORY OPINION INTRAVENOUS THERAPY BY LICENSED PRACTICAL NURSES
WYOMING STATE BOARD OF NURSING ADVISORY OPINION INTRAVENOUS THERAPY BY LICENSED PRACTICAL NURSES Advisory Opinion Number: 03-123 Board Meeting Date: April 28-May 1, 2003 January 7-10, 2008 February 18,
More informationIf viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.
If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Entity: Fairview Pharmacy Services Department:
More informationSARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY TITLE: NURSING AND PHARMACY GUIDELINES FOR THE ADMINISTRATION OF IV EPOPROSTENOL (FLOLAN, VELETRI ) POLICY #: EFFECTIVE DATE: REVISED DATE: POLICY
More informationTJC Corrective Actions. Nursing Education January, 2015
TJC Corrective Actions Nursing Education January, 2015 TJC Finding Normal Saline fluids stored in the warmer did not have the revised expiration dates. Normal Saline fluids stored in the warmer had a temperature
More informationSPECIMEN REQUIREMENTS
SPECIMEN REQUIREMENTS General Guidelines for Specimen Handling Specimen requirements generally include the requested volume, storage temperature, and any special handling notes. The requested volume provides
More informationCENTRAL IOWA HEALTHCARE Marshalltown, Iowa
CENTRAL IOWA HEALTHCARE Marshalltown, Iowa CARE OF PATIENT POLICY & PROCEDURES Policy Number: 4.37 Subject: Implanted Venous Access Device (Infus-A-Port), Nursing Management Of (Indwelling Vascular Access
More informationMARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa
MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa CARE OF PATIENT POLICY & PROCEDURES Policy Number: 4.37 Subject: Implanted Venous Access Device (Infus-A-Port), Nursing Management Of (Indwelling
More informationINTERPROFESSIONAL PROTOCOL - MUHC
INTERPROFESSIONAL PROTOCOL - MUHC Medication included No Medication included THIS IS NOT A MEDICAL ORDER Title: This interprofessional protocol is attached to: Definition Administration of Labile Blood
More informationRisk Assessment Form HS 9 (1)
s Full Name: Date of Birth: NHS Number 1. The fully implanted port system Sitimplant is not regularly used in the community and nursing staff may be unfamiliar with the recommended care of this system
More informationSARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY TITLE: NURSING AND PHARMACY GUIDELINES FOR THE ADMINISTRATION OF IV TREPROSTINIL (REMODULIN ) Job Title of Reviewer: Director, Pharmacy POLICY
More informationFacilitate arranging treatment around friends and family and organise social activities
Home Infusion Guide VPRIV (velaglucerase alfa for infusion) Gaucher disease, treatment and home infusion Together with your treating physician, you have decided to start home infusion therapy with VPRIV.
More informationRaleigh Parks and Recreation. Permission Form for Assisted Administration of Medication
Raleigh Parks and Recreation Permission Form for Assisted Administration of Medication Parks and Recreation employees only administer medication to participants if: 1. The City of Raleigh Permission Form
More informationCRAIG HOSPITAL POLICY/PROCEDURE
CRAIG HOSPITAL POLICY/PROCEDURE Approved: P&T, MEC, NPC, P&P 03/09 Effective Date: 02/95 P&T, MEC, P&P 08/09; P&P 08/10; P&T, MEC 10/10, P&T, P&P 12/10 ; MEC 01/11; P&T, MEC 02/11, 04/11 ; P&T, P&P 12/11
More informationMartin Health System Stuart, Florida Laboratory Services. Laboratory Services and Policies
Martin Health System Stuart, Florida Laboratory Services Laboratory Services and Policies Service Commitment: It is the goal of the Martin Health System s Clinical Laboratory to provide the medical community
More informationCyclophosphamide INFUSION Infusion 4 Plus
Cyclophosphamide Infusion Day DEPARTMENT OF RHEUMATOLOGY DAY CASE ADMISSION RECORD PATIENT DAY CASE BOOKING REQUEST To be completed by Consultant, Registrar requesting day case Admission Hospital No. Forename
More informationBlood Products Policy
Blood Products Policy Originator: Corinne Revens, Ward Sister Jane Creed, Senior Registered Nurse Miranda Green, Registered Nurse Review date: August 2013 Revision date: August 2015 Approved by: Clinical
More informationAdministration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016
Administration of blood components Denise Watson Patient Blood Management Practitioner 11th January, 2016 Introduction British Committee for Standards in Haematology guidelines Administration process Case
More informationCOURSE INFORMATION FORM
DATE SUBMITTED 6/24/13 CATALOG NO. PNUR 136 DATE DICC APPROVED 9/24/2013 DATE LAST REVIEWED 8/25/2009 DISCIPLINE COURSE TITLE COURSE INFORMATION FORM Practical Nursing Venous Access and Intravenous Infusion
More informationObjectives. With the completion of this module the learner will:
Specimen Labeling Objectives With the completion of this module the learner will: Identify the appropriate procedure for collecting and labeling specimens. Define patient identification requirements at
More informationCLINICAL GUIDE TO TRANSFUSION
Leonor De Biasio, RN, BScN, CPNC, and Tihiro Rymer, BScN, MLT BACKGROUND This chapter focuses on the principles of safe blood transfusion practices. The aim of this chapter is to develop and support the
More informationPeripherally Inserted Central Catheter
UW MEDICINE PATIENT EDUCATION Peripherally Inserted Central Catheter Understanding your PICC procedure and consent form Please read this handout before reading and signing the form Special Consent for
More informationLaboratory Services. Specimen Collection & Rejection Procedure
Laboratory Services Specimen Collection & Rejection Procedure According to both the Clinical Laboratory Improvement Amendment (CLIA) regulations and the College of American Pathologist s (CAP) Accreditation
More informationIntravenous Medication Administration via a Central Venous Line
Standard Operating Procedure 11 (SOP 11) Intravenous Medication Administration via a Central Venous Line Why we have a procedure? This procedure is to assist/ inform healthcare professionals on how to
More informationBaptist Health South Florida. Transfusion Services: Standardizing the Type & Screen Process Introducing Bar Code Blood Bands
Baptist Health South Florida Transfusion Services: Standardizing the Type & Screen Process Introducing Bar Code Blood Bands June 2011 O II. bjectives I. Review process for the Collection of Type & Screen
More informationACCOUNT NO. MED. REC. NO. NAME BIRTHDATE. Patient Identification ALL ORDERS MUST BE MARKED IN INK WITH A CHECKMARK ( ) TO BE ACTIVE.
PO7071 *PO7071* Page 1 of 4 ALL MUST BE MARKED IN INK WITH A CHECKMARK ( ) TO BE ACTIVE. Weight: kg Height: cm Allergies: Treatment Start Date: Date(s) of Transfusion(s): Current Labs: WBC: Hgb/Hct: Platelets:
More informationMedication Administration Skill Checklist (to be accompanied by daily medication log for applicable students) 1 page
See the following pages for exhibits relating to medical treatment: Exhibit A: Exhibit B: Exhibit C: Exhibit D: Exhibit E: Medication Administration Request Form and Guidelines for Administration of Medication
More informationDISTRICT NURSING and INTERMEDIATE CARE
CLINICAL GUIDELINES DISTRICT NURSING and INTERMEDIATE CARE Schedule of guidelines attached: DNICT03 Community Procedure for the Administration of Intravenous Drugs via Bolus The guidelines scheduled above
More informationStaff Responsible Procedure Rationale/Reason
Subject: Patient Controlled Analgesia Date: October 2011 UPMC St. Margaret UPMC St. Margaret Harmar Outpatient Center Clinical Practice Council Policy #2005 Overview: To promote appropriate PCA use and
More informationSTANDARDIZED PROCEDURE HEPATIC ARTERY INFUSION OF CHEMOTHERAPY (Adults, Peds)
I. Definition Hepatic arterial infusion (HAI) of chemotherapy is accomplished by a small drug delivery system or pump that is implanted in a subcutaneous pocket in the lower abdomen. The pump reservoir
More informationSTANDARDIZED PROCEDURE INTRAVENTRICULAR CHEMOTHERAPY VIA OMMAYA RESERVOIR (Adult, Peds)
I. Definition The administration of chemotherapy via Ommaya Reservoir into cerebrospinal fluid (CSF) for treatment of previously diagnosed central nervous system (CNS) involvement by leukemia and lymphoma
More informationInfliximab Infusion for Patients with Crohns Disease Patient Information Leaflet
Infliximab Infusion for Patients with Crohns Disease Patient Information Leaflet Originator: Lindsey Wood Date: March 2011 Version: 2 Date for Review: March 2014 DGOH Ref No: DGOH/PIL/00303 2 Contact Numbers
More informationRegistered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework
Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework Name: Location: Date commenced: Contents Competency: Page No: Page 1. Core: Introduction Demonstrate knowledge that
More informationAdverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN
Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Fairview Health Services 6 hospitals, ranging from rural
More informationCARE OF THE PATIENT REQUIRING CONTINUOUS FLOLAN INFUSION GUIDELINE
Page Number: 1 of 5 TITLE: CARE OF THE PATIENT REQUIRING CONTINUOUS FLOLAN INFUSION GUIDELINE PURPOSE: To provide guidelines for the nursing care of the patient with a Flolan infusion delivered thru continuous
More informationSUBCUTANEOUS IMMUNE GLOBULIN (SCIG) HOME INFUSION PROGRAM NLBCP-055. Issuing Authority
Government of Newfoundland and Labrador Department of Health and Community Services Provincial Blood Coordinating Program SUBCUTANEOUS IMMUNE GLOBULIN (SCIG) HOME INFUSION PROGRAM Office of Administrative
More informationPATIENT CARE MANUAL PROCEDURE
PATIENT CARE MANUAL PROCEDURE NUMBER III-130 PAGE 1 OF 5 APPROVED BY: CATEGORY: Vice President and Senior Operating Officer, Rural Health Services & Professional Practice Lead Medication Administration
More informationInfliximab Infusion for Patients with Ulcerative Colitis Patient Information Leaflet
Infliximab Infusion for Patients with Ulcerative Colitis Patient Information Leaflet Originator: Lindsey Wood Date: March 2011 Version: 2 Date for Review: March 2014 DGOH Ref No: DGOH/PIL/00304 Contact
More informationUNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM
Gilead Sciences, Inc. GS-US-248-0123, Amendment 1, 19-JUN-2012 A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with
More informationRecognizing and Reporting Acute Change of Condition
Recognizing and Reporting Acute Change of Condition Welcome to the Elizabeth McGowan Training Institute Cell Phones and Pagers Please turn your cell phones off or turn the ringer down during the session.
More informationSubacute Care. 1. Define important words in the chapter. 2. Discuss the types of residents who are in a subacute setting
175 26 Subacute Care 1. Define important words in this chapter 2. Discuss the types of residents who are in a subacute setting 3. List care guidelines for pulse oximetry 4. Describe telemetry and list
More informationPatient Self Administration of Intravenous (IV) Antibiotics at Home
Trust Policy Document Ref. No: PP(16)319 Patient Self Administration of Intravenous (IV) Antibiotics at Home For use in: For use by: For use for: Document owner: Status: Clinical Areas Clinical Staff Patient
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE BLOOD CULTURE COLLECTION PROCEDURE (spe20) DATE: REVIEWED: PAGES: 6/10 9/18 1 of 6 PS1094 ISSUED FOR: Nursing/Lab RESPONSIBILITY: RN, LPN II, select
More informationTitle: Massive Transfusion Event Protocol Policy: Clinical Manual/General Clinical
Title: Massive Transfusion Event Protocol Policy: Manual/General I. POLICY: Massive Transfusion Event (MTE) Protocol: The MTE Protocol is initiated at the request of the anesthesiologist, surgeon or physician
More informationSTANDARDIZED PROCEDURE LUMBAR DRAIN INSERTION (Adults, Peds)
I. Definition The purpose of this standardized procedure is for the Advanced Health Practitioner to safely place a lumbar drain. II. Background Information A. Setting: The setting (inpatient vs outpatient)
More informationNursing Guidelines on the Administration of Coagulation Factor Concentrate
Nursing Guidelines on the Administration of Coagulation Factor Concentrate Version Number 2 Date of Issue 2 nd April 2014 Reference Number Review Interval Approved By Name: Fionnuala O Neill Title: Chairperson
More informationBLOOD TRANSFUSION POLICY
Title: BLOOD TRANSFUSION POLICY Ref: 0219 Version 11 Classification: Guideline Directorate: Laboratory Medicine Due for Review: 15/12/2020 Document Control Responsible Consultant Haematologist and Transfusion
More informationAll About Your Peripherally Inserted Central Catheter (PICC)
All About Your Peripherally Inserted Central Catheter (PICC) General Information Intravenous (IV) therapy is the delivery of fluid directly into a vein. An intravenous catheter is a hollow tube that is
More informationMedication Storage and Security: The #1 Non- Complaint Medication Management Standard
Learning Objectives and Security: The #1 Non- Complaint Medication Management Standard d Manager, Army Patient Safety Program U.S. Army Medical Command Fort Sam Houston, TX Describe the importance of maintaining
More informationNursing Documentation Changes and Reminders. CCTC Nursing Documentation
Nursing Documentation Changes and Reminders CCTC Nursing Documentation Change #1 Standard ph range changed to match new RRT documentation Change #2 Clarification for documentation standards for IV solutions.
More informationPercutaneous Transhepatic Biliary Drainage Interventional Radiology
Percutaneous Transhepatic Biliary Drainage Interventional Radiology Your doctor has scheduled a percutaneous transhepatic biliary drainage to be done in the Interventional Radiology (IR) Department on
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More informationSUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure
SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure Subject: BLB 1 Procedures for Ordering Picking-up and Delivery of Blood Prepared By:
More informationAccreditation Program: Long Term Care
ccreditation Program: Long Term are National Patient Safety Goals indicates scoring category ; indicates scoring category ; indicates situational decision rules apply; indicates 2009 The Joint ommission
More informationContact Xofigo Access Services Today for Reimbursement Support
Quick Reference Guide Freestanding Center Updated January 2017 Quick Reference Reimbursement Guide Freestanding Center Contact ofigo Access Services Today for Reimbursement Support Phone: 1-855-6OFIGO
More informationThe Joint Commission Medication Management Update for 2010
Learning Objectives The Joint Commission Medication Management Update for 2010 U.S. Army Medical Command Fort Sam Houston, TX Describe most recent changes in The Joint Commission (TJC) Accreditation Program
More informationTo provide protocol for medication and solution labeling to ensure safe medication administration. Unofficial Copy
SUBJECT: MEDICATION / SOLUTION CONTAINER LABELING PURPOSE: To provide protocol for medication and solution labeling to ensure safe medication administration. POLICY: All medications, medication containers
More information201 KAR 20:490. Licensed practical nurse intravenous therapy scope of practice.
201 KAR 20:490. Licensed practical nurse intravenous therapy scope of practice. RELATES TO: KRS 314.011(10)(a), (c) STATUTORY AUTHORITY: KRS 314.011(10)(c), 314.131(1), 314.011(10)(c) NECESSITY, FUNCTION,
More informationSHARED HAEMODIALYSIS CARE HANDBOOK
SHARED HAEMODIALYSIS CARE HANDBOOK Name: Hospital Number: Shared Haemodialysis Care Named Nurse: Date: Machine Type: Dialysis Unit: INTRODUCTION CONTENTS Please tick the topic/procedure you are interested
More informationThe CMS State Operations Manual Overview and Changes
The CMS State Operations Manual Overview and Changes Omnicare, Inc. Page 1 Overview of the CMS State Operations Manual Executive Summary Historical Perspective The Requirements Pharmacy Services Labeling
More informationSAFE HANDLING OF HAZARDOUS MEDICATIONS (CYTOTOXIC AND NON-CYTOTOXIC) POLICY
SAFE HANDLING OF HAZARDOUS MEDICATIONS (CYTOTOXIC AND NON-CYTOTOXIC) POLICY POLICY # 110.160.010 NEWLY REVISED: OCTOBER 2015 AVAILABLE AT: HTTP://HOME.WRHA.MB.CA/PROG/MEDQUALITY/POLICIES.PHP Safe Handling
More informationSt. Vincent s Health System Page 1 of 8. Nursing Administration HOSPITAL SHARED POLICY?
St. Vincent s Health System Page 1 of 8 TITLE: Rapid Response Team FACILITY: St. Vincent s East FUNCTION: ORIGINATING DEPT: Nursing Administration HOSPITAL SHARED POLICY? EFFECTIVE DATE: _X_ Yes No DOCUMENT
More information1. Infection Control, Centers for Disease Control and Prevention (CDC). (2002). Guideline for hand hygiene in health-care settings
HOSPITAL CORPSMAN SKILLS BASIC (HMSB) MAY 8 Checklist (PCL) Clinical Skill: Intravenous Therapy Circle One: Initial Evaluation Re-Evaluation Command: A. INTRODUCTION Upon successful completion of this
More informationAIR FORCE CHILD AND YOUTH PROGRAMS MEDICATION ADMINISTRATION INSTRUCTIONAL GUIDE
AIR FORCE CHILD AND YOUTH PROGRAMS MEDICATION ADMINISTRATION INSTRUCTIONAL GUIDE September 2013 1. TRAINING OBJECTIVE: To assist CYP personnel (CYP staff and Family Child Care (FCC) providers) in understanding
More informationRequest for Severe Allergy Information
Request for Severe Allergy Information Dear Parent, You have disclosed that your child has a severe allergy. Wylie ISD requires additional information in order to take necessary precautions for your Child
More informationParagon Infusion Centers Patient Information
Paragon Infusion Centers Patient Information Please complete the following form as accurately as you are able. Inaccurate and/or incomplete information can delay our ability to authorize your treatments,
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES Medication Administration Observation
: Make random medication observations of several staff over different shifts and units, multiple routes of administration -- oral, enteral, intravenous (IV), intramuscular (IM), subcutaneous (SQ), topical,
More informationStorage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431
Centers for Medicare & Medicaid Services (CMS) Storage, Labeling, Controlled Medications Instructor s Guide CFR 483.60(b)(2)(3)(d)(e) F431 2006 Prepared by: American Institutes for Research 1000 Thomas
More information2. Short term prescription medication and drugs (administered for less than two weeks):
Medication Administration Procedure This is a companion document with Policy # 516 Student Medication To access the policy: click on Policies (under the District Information heading) The Licensed School
More informationSUNY DOWNSTATE MEDICAL CENTER UNIVERSITY HOSPITAL OF BROOKLYN POLICY AND PROCEDURE
SUNY DOWNSTATE MEDICAL CENTER UNIVERSITY HOSPITAL OF BROOKLYN POLICY AND PROCEDURE No: LAB-1 Subject: PROCEDURES FOR HANDLING Page 1 of 6 INPATIENT AND OUTPATIENT LABORATORY Prepared by: Dynesdal Wint
More informationTHE NEUMA PICC AND CENTRAL LINE PROTECTION CLAMP Introduction and Frequently Asked Questions
BACKGROUND The use of central lines for medical treatment is accelerating alongside an epidemic of intravenous drug abuse and opioid overdoses. Medical facilities are experiencing a dramatic need for safe
More informationStandard Of Nursing Care During Blood Transfusion
Standard Of Nursing Care During Blood Transfusion Blood transfusion carries potentially serious hazards. Nurses Observations that should be carried out before, during and after a transfusion SHOT aims
More informationINQUEST INTO THE DEATH OF: MARIE TANNER
INQUEST INTO THE DEATH OF: MARIE TANNER Details Name of Deceased: Marie Tanner Date of Death: January 21, 2002 Place of Death: Peterborough Regional Health Centre Cause of Death: Cardiac Arrest Caused
More information